Feasibility of combined biological treatments with omalizumab and non-IGE-targeting monoclonal antibodies: Novel insights and a mechanism-based approach

被引：0
|
作者：
Shamriz, O. [1 ]
Parnasa, E. [1 ]
Rubin, L. [1 ]
Talmon, A. [1 ]
Ribak, Y. [1 ]
Peleg, H. [1 ]
Confino-Cohen, R. [2 ]
Tal, Y. [1 ]
机构：
[1] Hadassah Ein Kerem Hosp, Jerusalem, Israel
[2] Meir Med Ctr, Kefar Sava, Israel
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
001404
引用
收藏
页码：95 / 95
页数：1
相关论文
共 4 条
  • [1] Exosomes and Exosomal Non-coding RNAs Are Novel Promises for the Mechanism-Based Diagnosis and Treatments of Atrial Fibrillation
    Chen, Chaofeng
    Chen, Qingxing
    Cheng, Kuan
    Zou, Tian
    Pang, Yang
    Ling, Yunlong
    Xu, Ye
    Zhu, Wenqing
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [2] Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors
    Tettamanti, Sarah
    Magnani, Chiara Francesca
    Biondi, Andrea
    Biagi, Ettore
    [J]. IMMUNOLOGY LETTERS, 2013, 155 (1-2) : 43 - 46
  • [3] TARGETING I2PP2A BY FTY720: A NOVEL, MECHANISM-BASED TREATMENT STRATEGY FOR PATIENTS WITH ADVANCED AND PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC).
    Saddoughi, Sahar
    Simon, George
    Mukhopadhyay, Archana
    Peterson, Yuri
    Liu, Angen
    Senkal, Can E.
    Oaks, Joshua
    Perrotti, Danilo
    Hannun, Yusuf
    Ogretmen, Besim
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S771 - S771
  • [4] Targeting I2PP2A by FTY720: A novel, mechanism-based treatment strategy for patients with advanced and previously treated non-small cell lung cancer (NSCLC).
    Simon, G. R.
    Saddoughi, S.
    Mukhopadhyay, A.
    Peterson, Y.
    Senkal, C. E.
    Oaks, J.
    Perrotti, D.
    Hannun, Y.
    Ogretmen, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
1